Transdermal Drug Delivery System-Design and Evaluation

International Journal of Advances in Pharmaceutical Sciences

Volumn 1, Issue 3, 2010, Pages 201-211

  Keleb, Eseldin ^a   Sharma, Rakesh Kumar ^b   B mosa, Esmaeil ^b   Z aljahwi, Abd alkadar ^b  

^a UNIVERSITY OF TRIPOLI   (Libyan Arab Jamahiriya)

^b AL Mergeb University   (Libyan Arab Jamahiriya)

Author keywords

Drug Delivery; TDDS; Transdermal

Indexed keywords

ALPRAZOLAM; ATENOLOL; BUPRENORPHINE; CAFFEINE; CARBEX; CLONIDINE; CYTARABINE; DRONABINOL; DRUG; ENALAPRIL; ENALAPRIL MALEATE; ESTRADIOL; ESTRADIOL PLUS NORETHISTERONE ACETATE; ETHINYLESTRADIOL PLUS NORELGESTROMIN; FENTANYL; GLYCERYL TRINITRATE; ISOSORBIDE DINITRATE; KETOROLAC; NICOTINE; PRAZOSIN; SALBUTAMOL; SALBUTAMOL SULFATE; SCOPOLAMINE; SELEGILINE; TESTOSTERONE;

ALLERGIC REACTION; APPLICATION SITE IRRITATION; DOSE RESPONSE; DRUG ABSORPTION; DRUG ADMINISTRATION ROUTE; DRUG APPROVAL; DRUG BLOOD LEVEL; DRUG DEGRADATION; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG DOSAGE FORM COMPARISON; DRUG PENETRATION; DRUG RESEARCH; DRUG SCREENING; FIRST PASS EFFECT; GASTROINTESTINAL SYMPTOM; HALF LIFE TIME; HUMAN; HYDROPHILICITY; MAXIMUM PLASMA CONCENTRATION; MICROCIRCULATION; MOISTURE; MOLECULAR SIZE; MOTION SICKNESS; NONHUMAN; PATIENT COMPLIANCE; PHYSICAL CHEMISTRY; PRODUCT DEVELOPMENT; REVIEW; SKIN; SKIN STRUCTURE; TENSILE STRENGTH; THICKNESS; TRANSDERMAL PATCH; WEIGHT;

EID: 79953220580     PISSN: None     EISSN: 09761055     Source Type: Journal    
DOI: 10.5138/ijaps.2010.0976.1055.01026     Document Type: Review

References (27)

1. Jasti BR, Abraham W, Ghosh TK. Transdermal and Topical drug delivery systems. In: Ghosh TK, Jasti BR, editors. Theory and Practice of Contemporary Pharmaceutics. 1st ed. Florida: CRC Press; 2005. p. 423-453.
2. Baker H. The skin as barrier. In: Rook A, Wilkinson DS, Ebling FJG, Champion RH, Burton JL, eds. Text Book of Dermatology. Vol. I, 4th ed. Oxford: Blackwell Scientific Publications, 1986:355-366.
3. Barr M. Percutaneous absorption, J Pharm Sci 1962; (61):395-409.
4. Chein YW. Advances in transdermal systemic drug delivery. Drugs of Future 1988; (13):343-362.
5. Franz TJ, Tojo K. Shah KR, Kydonieus A. Transdermal delivery. In: A Kydonieus, ed. Treatise on Controlled Drug Delivery. New York: Marcel Dekker, 1992:341-421.
6. Prochazka AV. New developments in smoking cessation. Chest. 2000;117 (4 Suppl1):169-175.
7. Hadgraft J. Modulation of the barrier function of the skin. Skin Pharmacol Appl Skin Physiol. 2001;(14)(suppl 1):72-81.
8. Chein YW. Novel Drug Delivery Systems Revised and expanded. 2nd ed. New York: Marcel Dekker Inc; 2005. 9.
9. Riviere JE, Papich MG. Potential and problems of developing transdermal patches for veterinary applications. Adv Drug Deliv Rev. 2001;(50):175-203.
10. Chandrashekar NS, Shobha Rani RH. Physicochemical and pharmacokinetic parameters in drug selection and loading for transdermal drug delivery. Indian J Pharm Sci 2008;(70):94-96
11. Panchagnula R. Transdermal delivery of drugs. Indian J Pharmacol 1997;(29): 140-156.
12. Sadashivaiah R, Dinesh BM, Patil UA, Desai BG, Raghu KS. Design and in vitro evaluation of haloperidol lactate transdermal patches containing ethyl cellulose-povidone as film formers. Asian J Pharm 2008;(2):43-49
13. Taub MB, Dauskardt RH. Adhesion of pressure sensitive adhesives with applications in transdermal drug delivery. In: Mallapragada S, Korsmeyer R, Mathiowitz E, et al, eds. Biomaterials for Drug Delivery and Tissue Engineering. Warrendale, Pa, [Mater. Res. Soc. Proc.662,2001].
14. Arora P, Mukherjee P. Design, development, physicochemical, and in vitro and in vivo evaluation of transdermal patches containing diclofenac diethylammonium salt. J Pharm Sci 2002;(91):2076-2089.
15. Tojo K. Design and calibration of in vitro permeation apparatus. In: Chien YW, editor. Transdermal controlled systemic medications. New York: Marcel Dekker; 1987. p. 127-158.
16. Mukherjee B, Mahapatra S, Gupta R, Patra B, Tiwari A, Arora P. A comparison between povidone-ethylcellulose and povidone-eudragit transdermal dexamethasone matrix patches based on in vitro skin permeation. Eur J Pharma Biopharma 2005;(59):475-483
17. McCarley KD, Bunge AL. Review of pharmacokinetic models of dermal absorption. J Pharmaceut Sci. 2001;(90):1699-1719.
18. Ghosal SK, Bhattacharya M, Mandal SC. Invitro release and permeation kinetics of pentazocaine from matrix dispersion type transdermal drug delivery systems. Drug Dev Ind Pharm 1994;(20):1933-41.
19. Guyot M, Fawaz F. Design and in vitro evaluation of adhesive matrix for transdermal delivery of propranolol. Int J Pharm. 2000;(204):171-182.
20. Bronaugh RL., Stewart RF, Congdon ER. (1982) Methods for in vitro percutaneous absorption studies II. Animal models for human skin. Toxicol App Pharmacol 1982;(62):481-488.
21. Wester RC, Noonan PK. Relevance of animal models for percutaneous absorption. Int J Pharm 1980:(7):99-110.
22. Lin, R-Y., Hsu, C-W. and Chein, YW. A method to predict the transdermal permeability of amino acids and dipeptides through porcine skin. J Cont Rel 1996;(38):229-34.
23. Benson HA. Transdermal drug delivery: Penetration enhancement techniques. Curr Drug Deliv 2005; (2):23-33.
24. Baynes RE, Monteiro-Riviere NA, Qiao GL, Riviere JE. Cutaneous toxicity of the benzidine dye direct red 28 applied as mechanistically defined chemical mixtures (MDCM) in perfused porcine skin. Toxicol Lett. 1997;(93):159-169.
25. Riviere JE, Papich MG. Potential and problems of developing transdermal patches for veterinary applications. Adv Drug Deliv Rev. 2001;(50):175-203.
26. Morganti P, Ruocco E, Wolf R, Ruocco V. Percutaneous absorption and delivery systems. Clin Dermatol. 2001;(19):489-501.
27. Mehta R. Topical and transdermal drug delivery: What a pharmacist needs to know. Available at: www.inetce.com/articles/pdf/146-000-01-008